medmix AG - Asset Resilience Ratio

Latest as of December 2025: 11.75%

medmix AG (MEDX) has an Asset Resilience Ratio of 11.75% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MEDX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CHF113.90 Million
≈ $144.00 Million USD Cash + Short-term Investments

Total Assets

CHF969.30 Million
≈ $1.23 Billion USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how medmix AG's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see MEDX asset base.

Liquid Assets Composition Over Time

This chart breaks down medmix AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read MEDX total debt and obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CHF105.50 Million 10.88%
Short-term Investments CHF8.40 Million 0.87%
Total Liquid Assets CHF113.90 Million 11.75%

Asset Resilience Insights

  • Moderate Liquidity: medmix AG has 11.75% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

medmix AG Industry Peers by Asset Resilience Ratio

Compare medmix AG's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Vestas Wind Systems A/S
CO:VWS
Specialty Industrial Machinery 0.62%
Schindler Holding AG
SW:SCHN
Specialty Industrial Machinery 36.46%
Symbotic Inc
NASDAQ:SYM
Specialty Industrial Machinery 0.00%
Sulzer AG
SW:SUN
Specialty Industrial Machinery 0.00%
X-Energy, Inc. Class A Common Stock
NASDAQ:XE
Specialty Industrial Machinery 21.72%
Suzhou Secote Precision Electronic Co Ltd Class A
SHG:603283
Specialty Industrial Machinery 1.25%
Sandvik AB
ST:SAND
Specialty Industrial Machinery 2.92%
NARI Technology Co Ltd
SHG:600406
Specialty Industrial Machinery 16.07%

Annual Asset Resilience Ratio for medmix AG (2018–2025)

The table below shows the annual Asset Resilience Ratio data for medmix AG.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.18% CHF11.40 Million
≈ $14.41 Million
CHF969.30 Million
≈ $1.23 Billion
+0.94pp
2024-12-31 0.24% CHF2.30 Million
≈ $2.91 Million
CHF954.20 Million
≈ $1.21 Billion
-0.04pp
2023-12-31 0.28% CHF2.80 Million
≈ $3.54 Million
CHF1.01 Billion
≈ $1.27 Billion
-18.84pp
2022-12-31 19.12% CHF211.40 Million
≈ $267.27 Million
CHF1.11 Billion
≈ $1.40 Billion
+19.02pp
2021-12-31 0.09% CHF900.00K
≈ $1.14 Million
CHF974.40 Million
≈ $1.23 Billion
-4.02pp
2020-12-31 4.11% CHF32.50 Million
≈ $41.09 Million
CHF789.90 Million
≈ $998.65 Million
-6.83pp
2019-12-31 10.95% CHF76.30 Million
≈ $96.46 Million
CHF697.00 Million
≈ $881.20 Million
+1.30pp
2018-12-31 9.65% CHF69.30 Million
≈ $87.61 Million
CHF718.10 Million
≈ $907.87 Million
--
pp = percentage points

About medmix AG

SW:MEDX Switzerland Specialty Industrial Machinery
Market Cap
$463.31 Million
CHF366.46 Million CHF
Market Cap Rank
#14186 Global
#149 in Switzerland
Share Price
CHF9.01
Change (1 day)
+0.22%
52-Week Range
CHF7.87 - CHF12.08
All Time High
CHF44.71
About

medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for pros… Read more